Medroxyprogesterone Acetate 150 mg / mL Injection Single-Dose Vial 1 mL by Xiromed ID 70700-0315-27

Rally #200-7-3527
NDC #70700-315-27
Xiromed - MedroxyProgesterone Acetate Injectable Suspension, USP
Sold As: 1 Each

Injectable Suspension, 150 mg / 1 ml, 1 × 1 mL Vials, Sterile Aqueous, Intramuscular Injection, Contains Preservatives

• Clinically equivalent to the reference brand for safety and efficacy.
• Pre-measured for precise, sterile intramuscular administration.
• Container closure is not made with natural rubber latex or dry natural rubber.
• Stable for up to 24 months under recommended storage conditions.

Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL (NDC 70700-315-27) by Xiromed is an FDA-approved injectable progestin used for long-acting hormonal therapy. It is AB-rated for therapeutic equivalence and meets rigorous quality and safety standards. The product is designed for intramuscular use and features a latex-free container closure to minimize allergen exposure. With a 24-month shelf life, it offers long-term stability and is suitable for use in clinical and institutional settings.

Important Notes:

• Restricted Product: Rx Only - Current Valid Medical License Required.
• This product is non-returnable. Please verify your ordering information before making a purchase.

For the State of California:
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Please see Education and Documents section for Prescribing Information.


Size: 150MG 1ML